144 related articles for article (PubMed ID: 7492643)
1. Efficacy of florfenicol on experimental Actinobacillus pleuropneumonia in pigs.
Ueda Y; Ohtsuki S; Narukawa N
J Vet Med Sci; 1995 Apr; 57(2):261-5. PubMed ID: 7492643
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of florphenicol premix in weanling pigs experimentally infected with Actinobacillus pleuropneumoniae.
Palacios-Arriaga JM; Gutierrez-Pabello JA; Chavez-Gris G; Hernandez-Castro R
Rev Latinoam Microbiol; 2000; 42(1):27-33. PubMed ID: 10948826
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral enrofloxacin and florfenicol on pigs experimentally infected with Actinobacillus pleuropneumoniae serotype 1.
Herradora LM; Martínez-Gamba R
J Vet Med A Physiol Pathol Clin Med; 2003 Jun; 50(5):259-63. PubMed ID: 14567514
[TBL] [Abstract][Full Text] [Related]
4. In vitro antibacterial activity of florfenicol against Actinobacillus pleuropneumoniae.
Ueda Y; Suenaga I
J Vet Med Sci; 1995 Apr; 57(2):363-4. PubMed ID: 7492665
[TBL] [Abstract][Full Text] [Related]
5. Experimental infections with Actinobacillus pleuropneumoniae in pigs--II. Comparison of antibiotics for oral strategic treatment.
Wallgren P; Segall T; Pedersen Mörner A; Gunnarsson A
Zentralbl Veterinarmed B; 1999 May; 46(4):261-9. PubMed ID: 10379236
[TBL] [Abstract][Full Text] [Related]
6.
Papatsiros V; Tzika E; Athanasiou L; Tassis P; Chaintoutis S; Christodoulopoulos G
Microb Drug Resist; 2019 May; 25(4):603-610. PubMed ID: 30562148
[TBL] [Abstract][Full Text] [Related]
7. Tissue pharmacokinetics of florfenicol in pigs experimentally infected with Actinobacillus pleuropneumoniae.
Li JZ; Fung KF; Chen ZL; Zeng ZL; Zhang J
Eur J Drug Metab Pharmacokinet; 2002; 27(4):265-71. PubMed ID: 12587956
[TBL] [Abstract][Full Text] [Related]
8. Serological characterisation and antimicrobial susceptibility of Actinobacillus pleuropneumoniae strains isolated from pigs in Spain.
Gutiérrez CB; Rodríguez Barbosa JI; Tascón RI; Costa L; Riera P; Rodríguez Ferri EF
Vet Rec; 1995 Jul; 137(3):62-4. PubMed ID: 8533233
[TBL] [Abstract][Full Text] [Related]
9. A Florfenicol-Resistant Plasmid Shuttling Between
Zhu C; Cai J; An J; Zhang B; Li Y
Microb Drug Resist; 2024 Apr; 30(4):175-178. PubMed ID: 38364190
[TBL] [Abstract][Full Text] [Related]
10. Serotypes and antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from piglets with pleuropneumonia.
Asawa T; Kobayashi H; Mitani K; Ito N; Morozumi T
J Vet Med Sci; 1995 Aug; 57(4):757-9. PubMed ID: 8519914
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of florfenicol in healthy pigs and in pigs experimentally infected with Actinobacillus pleuropneumoniae.
Liu J; Fung KF; Chen Z; Zeng Z; Zhang J
Antimicrob Agents Chemother; 2003 Feb; 47(2):820-3. PubMed ID: 12543702
[TBL] [Abstract][Full Text] [Related]
12. Immunohistological evaluation on respiratory lesions of pigs intranasally inoculated with Actinobacillus pleuropneumoniae serotype 1.
Ajito T; Haga Y; Homma S; Goryo M; Okada K
J Vet Med Sci; 1996 Apr; 58(4):297-303. PubMed ID: 8741260
[TBL] [Abstract][Full Text] [Related]
13. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Blondeau JM; Fitch SD
PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
[TBL] [Abstract][Full Text] [Related]
14. Changes in antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Spain during the last decade.
Gutiérrez-Martín CB; del Blanco NG; Blanco M; Navas J; Rodríguez-Ferri EF
Vet Microbiol; 2006 Jun; 115(1-3):218-22. PubMed ID: 16431040
[TBL] [Abstract][Full Text] [Related]
15. Serotype diversity and antimicrobial susceptibility profiles of Actinobacillus pleuropneumoniae isolated in Italian pig farms from 2015 to 2022.
Guarneri F; Romeo C; Scali F; Zoppi S; Formenti N; Maisano AM; Catania S; Gottschalk M; Alborali GL
Vet Res; 2024 Apr; 55(1):48. PubMed ID: 38594744
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pharmacokinetics of tilmicosin in healthy pigs and pigs experimentally infected with
Xiong J; Zhu Q; Yang S; Zhao Y; Cui L; Zhuang F; Qiu Y; Cao J
N Z Vet J; 2019 Sep; 67(5):257-263. PubMed ID: 31208293
[No Abstract] [Full Text] [Related]
17. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolates from clinical outbreaks of porcine respiratory diseases.
Kucerova Z; Hradecka H; Nechvatalova K; Nedbalcova K
Vet Microbiol; 2011 May; 150(1-2):203-6. PubMed ID: 21316872
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of a mobilisable plasmid conferring florfenicol and chloramphenicol resistance in Actinobacillus pleuropneumoniae.
Bossé JT; Li Y; Atherton TG; Walker S; Williamson SM; Rogers J; Chaudhuri RR; Weinert LA; Holden MT; Maskell DJ; Tucker AW; Wren BW; Rycroft AN; Langford PR;
Vet Microbiol; 2015 Aug; 178(3-4):279-82. PubMed ID: 26049592
[TBL] [Abstract][Full Text] [Related]
19. Serotyping and quantitative determination of in vitro antibiotic susceptibility of Actinobacillus pleuropneumoniae strains isolated in Belgium (July 1991-August 1992).
Dom P; Hommez J; Castryck F; Devriese LA; Haesebrouck F
Vet Q; 1994 Mar; 16(1):10-3. PubMed ID: 8009811
[TBL] [Abstract][Full Text] [Related]
20. Recent trends in antimicrobial susceptibility and the presence of the tetracycline resistance gene in Actinobacillus pleuropneumoniae isolates in Japan.
Morioka A; Asai T; Nitta H; Yamamoto K; Ogikubo Y; Takahashi T; Suzuki S
J Vet Med Sci; 2008 Nov; 70(11):1261-4. PubMed ID: 19057148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
